Skip to Content


Office of Biotechnology Activities; Recombinant DNA Research: Amended Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


Notice of cancellation of consideration of a proposed action Start Printed Page 31796under Section III-A-1 of the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines).


Notice of a discussion of a proposed action under Section III-A-1 published on May 24, 2010 (75 FR 28811) is withdrawn. The discussion that was to be held at the June 16-17, 2010 meeting of the NIH Recombinant DNA Advisory Committee has been deferred at the request of the principal investigator.

Start Further Info


OBA by e-mail at, or telephone at 301-496-9838, if you have questions, or require additional information.

Start Signature

Dated: May 26, 2010.

Jacqueline Corrigan-Curay,

Acting Director, Office of Biotechnology Activities, National Institutes of Health.

End Signature End Further Info End Preamble

[FR Doc. 2010-13484 Filed 6-3-10; 8:45 am]